U.S. Lipid Therapeutics Market

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

This research service analyzes the changing dynamics in the U.S. lipid therapeutics market from the period 2001-2011. Included are pipeline analysis, patient forecasts, and individual product revenue forecasts for the major products. Both products currently in the market, as well as those forecast to enter the market by 2011 are included, with an emphasis on branded drug products. The market is segmented by product class: statins, single pill combination products, cholesterol absorption inhibitors, fibrates, nicotinic acid derivatives, and bile acid sequestrants. Also included is a pipeline overview of products operating by new mechanisms of action. The products covered in this research service are used in the treatment of dyslipidemia.

Table of Contents

U.S. Lipid Therapeutics Market, Executive SummaryExecutive SummaryIntroductionU.S. Lipid Therapeutics Market, Total MarketResearch Scope & MethodologyScope and SegmentationResearch MethodologyOverviewIntroductionLipids and LipoproteinsDyslipidemiaRisk FactorsNCEP GuidelinesTreatment OverviewDiet/Functional FoodsAdherenceMarket Engineering MeasurementsTotal Market ForecastsRevenue ForecastsMarket Share AnalysisPatient ForecastsPrevalence of Elevated Total CholesterolPrevalence of Low HDL-CPatients on Drug TherapyGeneral Market TrendsIndustry ChallengesMarket DriversMarket RestraintsCompetitive StructureOverviewFrost & Sullivan AwardsMarket Leadership of the Year AwardCompetitive Strategy Leadership of the Year AwardProduct of the Year AwardProduct Line Strategy of the Year AwardTechnology Innovation of the Year AwardU.S. Lipid Therapeutics Market, Statins MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsLipitor ForecastZocor ForecastPravachol ForecastLescol ForecastCrestor ForecastGenerics ForecastTotal Statins Market ForecastMarket Share AnalysisU.S. Lipid Therapeutics Market, Single Pill Combination Products MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsVytorin ForecastAdvicor ForecastKS01019 ForecastTorcetrapib/Atorvastatin ForecastTotal Single Pill Combination Products MarketMarket Share AnalysisU.S. Lipid Therapeutics Market, Cholesterol Absorption Inhibitors MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsZetia ForecastU.S. Lipid Therapeutics Market, Fibrates MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsTricor ForecastNew FenofibratesTotal Fibrates MarketMarket Share AnalysisU.S. Lipid Therapeutics Market, Nicotinic Acid Derivatives MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisPipeline AnalysisMarket ForecastsNiaspan ForecastU.S. Lipid Therapeutics Market, Bile Acid Sequestrants MarketOverviewIntroductionMarket Engineering MeasurementsProduct AnalysisMarket ForecastsWelchol ForecastTotal Bile Acid Sequestrants MarketMarket Share AnalysisU.S. Lipid Therapeutics Market, New Mechanism ProductsOverviewIntroductionPipeline AnalysisU.S. Lipid Therapeutics Market, AppendixDecision Support DatabasesMortality Due to Coronary Heart DiseasePrevalence of Obesity in the Population Over 15 Years of AgeIncidence of Myocardial InfarctionMortality Due to Myocardial InfarctionIncidence of Stroke




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.